"Herb-Drug Interactions" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The effect of herbs, other PLANTS, or PLANT EXTRACTS on the activity, metabolism, or toxicity of drugs.
Descriptor ID |
D041743
|
MeSH Number(s) |
G07.690.773.968.755
|
Concept/Terms |
Herb-Drug Interactions- Herb-Drug Interactions
- Herb Drug Interactions
- Herb-Drug Interaction
- Interaction, Herb-Drug
- Interactions, Herb-Drug
- Herbal Drug Interactions
- Drug Interaction, Herbal
- Drug Interactions, Herbal
- Herbal Drug Interaction
- Interaction, Herbal Drug
- Interactions, Herbal Drug
- Drug-Plant Interactions
- Drug Plant Interactions
- Drug-Plant Interaction
- Interaction, Drug-Plant
- Interactions, Drug-Plant
- Plant-Drug Interactions
- Interaction, Plant-Drug
- Interactions, Plant-Drug
- Plant Drug Interactions
- Plant-Drug Interaction
- Drug-Herb Interactions
- Drug Herb Interactions
- Drug-Herb Interaction
- Interaction, Drug-Herb
- Interactions, Drug-Herb
|
Below are MeSH descriptors whose meaning is more general than "Herb-Drug Interactions".
Below are MeSH descriptors whose meaning is more specific than "Herb-Drug Interactions".
This graph shows the total number of publications written about "Herb-Drug Interactions" by people in this website by year, and whether "Herb-Drug Interactions" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2007 | 0 | 1 | 1 |
2011 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Herb-Drug Interactions" by people in Profiles.
-
Metabolism of ginseng and its interactions with drugs. Curr Drug Metab. 2011 Nov; 12(9):818-22.
-
The effect of complimentary and alternative medicine products on laboratory testing. Semin Diagn Pathol. 2009 Feb; 26(1):38-48.
-
Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making. J Clin Oncol. 2007 Feb 10; 25(5):548-54.